Nuvilex - NVLX

Nuvilex (NVLX)
Coverage: March 1, 2013 - March 1, 2014
Featured: March 1, 2013

Latest Newsletter Editions

spacer
Fri, Oct 17, 2014 @ 07:10 am
Hedge Fund Managers- Drowning At Their High Water Marks It seems like we might have had the capitulation sell off this week, with...
Mon, Jul 21, 2014 @ 06:07 am
Nuvilex (NVLX): Shutting Them Up It's been the only thing worth covering in July-It's been radio silence from Staffing 360 (STAF...
Sun, Jul 13, 2014 @ 08:07 am
Nuvilex (NVXL): A Tradeable Bottom? Well, it's July and we're in the middle of the summer doldrums. Microcap stocks are exceptionally...
Fri, May 30, 2014 @ 09:05 am
Nuvilex (NVLX): Don't Be Fooled By Quiet Trading It's been a rather quiet week on the trading front for Nuvilex (NVLX), but it's anything but quiet on the corporate front. It's...
Thu, May 1, 2014 @ 09:05 am
Nuvilex (NVLX): Proving My Theory Today The last edition I published on Nuvilex (NVLX) back on April 19th suggested we had finally...

Click Here For More Newsletters on NVLX

spacer

Latest Blog Entries

spacer

Quote Data

spacer
Last Trade: N/A Bid: 0.0000
Last Size: 0 Ask: 0.0000
Trade Time: N/A Bid x Ask Size: N/A
Change: +0.0000 (+0.00%) Day's Range: 0.00 - 0.00
Prev Close: 0.0000 52wk Range: 0.00 - 0.00
Open: 0.0000 P/E (ttm): N/A
Volume: 0 EPS (ttm): -0.03
spacer [Chart]

Business Summary

spacer

Disclosure

spacer
MarketBtye LLC was formerly paid a fee of $10,000 and 1 million newly issued restricted shares of Nuvilex by the company for six months of coverage. The 6 months has expired. On November 1, 2013, MarketByte LLC entered into a consulting agreement with Nuvilex to cover the company for an additional 6 months and received 300,00 newly issued restricted shares. MarketByte LLC currently holds no shares of Nuvilex, and has received $83,155.83 in proceed from sales of NVLX in 2014. At present, MarketByte LLC has no contractual obligation to provide coverage of Nuvilex. Therefore, there are no conflicts of interest.

Recent News Headlines

spacer
PharmaCyte Biotech Diabetes Consortium Member Publishes Review Article on Use of Genetic Engineering to Treat Diabetes
Fri, 13 Feb 2015 15:54:38 GMT
[at noodls] - PharmaCyte Biotech Diabetes Consortium Member Publishes Review Article on Use of Genetic Engineering to Treat Diabetes